Keeninvestment I have to admit that I have little understanding of the medical device/ heart valve development process. We have been given the results of the anti-calcification comparison and the results of the bench testing of the various valves but how does a company do a head to head clinical trial against major competitors? Do we need those competitors to agree to the trial or is it something that AVR can implement of its own accord?
Keeninvestment I have to admit that I have little understanding...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.00 |
Change
-0.350(2.02%) |
Mkt cap ! $327.3M | |||
| Open | High | Low | Value | Volume |
| $17.00 | $17.44 | $16.95 | $150.7K | 8.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 388 | $17.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.13 | 35 | 2 |
View Market Depth
| Last trade - 11.26am 19/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |